OrsoBio Alternatives & Competitors
12 companies similar to OrsoBio — Advancing first-in-class therapies to restore energy homeostasis
Companies similar to OrsoBio
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
Conshohocken, United Stat...
BioAge Labs
We are harnessing the biology of human aging to develop novel targets and therapies for me...
Emeryville, United States
Glyscend Therapeutics
Advancing a new class of oral gut-targeted polymeric drugs for the treatment of T2D and Ob...
Lowell, United States
Rival Readout
Competing with OrsoBio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Intellia Therapeutics, Inc.
Developing curative genome editing treatments
Cambridge, United States
NorthSea Therapeutics
Clinical-stage biopharmaceutical company focused on the development of structurally engine...
Amsterdam, The Netherland...
Edgewise Therapeutics
On a mission to improve the lives of people facing serious muscle disease.
Boulder, United States
Cirius Therapeutics
Pioneering the future of liver and metabolic disease treatment with innovative insulin sen...
Ansun Biopharma, Inc.
Discovering solutions for the world
San Diego, United States
Petra Pharma
Pioneering novel therapies to address cancer and metabolic disorders by targeting essentia...
Walden Biosciences
Transforming the Treatment of Kidney Disease
Cambridge, United States
Synnovation Therapeutics
A precision oncology company focused on small molecule therapies optimized to target key d...
Wilmington, United States
About OrsoBio
OrsoBio, founded in 2021, is a United States-based, clinical-stage biopharmaceutical company aiming to transform the treatment of severe metabolic disorders. Guided by its slogan, "Advancing first-in-class therapies to restore energy homeostasis", the company focuses on innovative treatments for conditions such as type...
Developing first-in-class therapies, Targeting energy metabolism pathways, Restoring energy homeostasis
Patients with severe metabolic disorders, Individuals with obesity and diabetes, Healthcare providers focused on metabolic health
First-in-class Therapies, Energy Homeostasis, Metabolic Disorders, Type 2 Diabetes, Severe Dyslipidemias, Lipodystrophies, Nonalcoholic Steatohepatitis, Clinical-stage Biopharmaceutical, Energy Metabolism Pathways, Therapeutics Development, Restoring Energy Balance, Underlying Cause Treatment, Severe Metabolic Conditions, Private Healthcare Innovation, Biopharmaceutical Research
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around OrsoBio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at OrsoBio on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
